Jules Müsing
Director/Board Member at Delphi Digital, Inc.
Jules Müsing active positions
| Companies | Position | Start | End |
|---|---|---|---|
Delphi Digital, Inc.
 Delphi Digital, Inc. Internet Software/ServicesTechnology Services Delphi Digital, Inc. engages in the provision of internet services. It offers an online personal management tools to individuals, families, and organizations. The company is headquartered in Rancho Mirage, CA. | Director/Board Member | 2012-02-29 | - |
Career history of Jules Müsing
Former positions of Jules Müsing
| Companies | Position | Start | End |
|---|---|---|---|
| THERAPEUTICSMD, INC. | Director/Board Member | 2013-05-15 | 2022-12-29 |
| Independent Dir/Board Member | 2013-05-15 | 2022-12-29 | |
| IBIO, INC. | Director/Board Member | 2011-12-31 | 2013-12-31 |
| Independent Dir/Board Member | 2011-12-31 | 2013-12-31 | |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 2002-12-31 | 2010-08-31 |
Biotech Ortho SAS
 Biotech Ortho SAS Medical DistributorsDistribution Services Part of Stryker Corp., Biotech Ortho SAS is a French company that wholesales pharmaceutical products. The company is based in Salon-de-Provence, France. | Chief Executive Officer | 1999-09-30 | 2002-12-31 |
| Ortho Biotech, Inc. | Director/Board Member | 1992-12-31 | 1999-09-30 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | President | 1990-03-31 | 1992-12-31 |
| Janssen Farmaceutica Portugal Lda. | Chief Executive Officer | 1987-06-30 | 1990-02-28 |
| Pitman-Moore, Inc. | President | 1984-12-31 | 1987-05-31 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Jules Müsing
| University of Antwerp | Undergraduate Degree |
| Vrije Universiteit Brussel | Graduate Degree |
Statistics
International
| United States | 9 |
| Belgium | 3 |
| France | 2 |
Operational
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| President | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| IBIO, INC. | Health Technology |
| THERAPEUTICSMD, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private companies | 7 |
|---|---|
Delphi Digital, Inc.
Delphi Digital, Inc. Internet Software/ServicesTechnology Services Delphi Digital, Inc. engages in the provision of internet services. It offers an online personal management tools to individuals, families, and organizations. The company is headquartered in Rancho Mirage, CA. | Technology Services |
| Pitman-Moore, Inc. | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Ortho Biotech, Inc. | |
Biotech Ortho SAS
Biotech Ortho SAS Medical DistributorsDistribution Services Part of Stryker Corp., Biotech Ortho SAS is a French company that wholesales pharmaceutical products. The company is based in Salon-de-Provence, France. | Distribution Services |
| Janssen Farmaceutica Portugal Lda. | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
- Stock Market
- Insiders
- Jules Müsing
- Experience
